News Unlocking a New Milestone: US FDA Grants QIDP Status to VRP-034! We are proud to share a landmark achievement in our journey at Venus Remedies Limited—one that shines a global spotlight on India’s role in tackling one of the world’s most pressing healthcare challenges: antimicrobial resistance (AMR). The U.S. Food and Drug Administration (FDA) has awarded Qualified
partnership Venus Remedies x Infex to Combat Antimicrobial Resistance in India Congratulations, Venusians. We have yet again marked another day on the calendar with gold! Venus Remedies Ltd. is delighted to announce a significant partnership with UK-based anti-infective drug development company, Infex Therapeutics. The alliance aims to tackle drug-resistant Gram-negative bacterial infections via MET-X, an innovative metallo-beta-lactamase (MBL) inhibitor. Under this
The Grand Launch Featured Mrs. Ekta S. Chaudhary to Lead Venus Foundation We are immensely honored and delighted to announce the appointment of Mrs. Ekta S. Chaudhary as the new Chairperson of Venus Foundation. We are certain that this significant milestone will mark a new era of growth, inclusivity, and impactful change under her visionary leadership. Her presence adds not only strength
News Featured Venus Remedies partners with UK-based Infex Therapeutics to develop anti-bacterial MET-X in India Bringing a First-in-Class MBL Inhibitor to India: Venus Remedies Licenses MET-X Venus Remedies has taken a significant step in combating Antimicrobial Resistance (AMR) by securing exclusive licensing rights for MET-X, an innovative anti-bacterial drug from UK-based Infex Therapeutics. This landmark partnership will enable Venus Remedies to develop, gain regulatory approvals,
Venus Advances Its Efforts in Upgrading the Adopted School Venus adopted the Government Model Sanskriti Primary School in Sector 19, Panchkula, in late 2023. Since then, it has been committed to bringing substantial changes to fulfill its mission of uplifting the school, focusing on improving its infrastructure and creating a more enriching learning environment. Through its meaningful, thoughtful, and
Venus Graduation Ceremony 2024: The First 2024 witnessed several new endeavors at Venus Remedies Limited, one of which was our grand 'Venus Graduation Ceremony.' This ceremony was not a regular 'certificates and congratulations' graduation. It was a magnificent celebration honoring the hard work, dedication, and growth of 128 employees who successfully completed their NSDC certifications,
Venus Remedies Secures GMP Certification from Moldova for Antibiotic-Carbapenem Manufacturing Facility Venus Remedies proudly announces its latest achievement: receiving Good Manufacturing Practices (GMP) certification from the Ministry of Health of Moldova for its antibiotic-carbapenem manufacturing facility. This certification was granted after a comprehensive inspection conducted in October 2024, with final approval granted in December 2024. This achievement reaffirms the company’s
Bulletin Venus Remedies Achieves GMP Certification for Panchkula Infusion Line by Iraq Venus Remedies is yet again proud to announce a significant achievement in our journey toward excellence. Our Panchkula infusion line has received the prestigious GMP (Good Manufacturing Practices) certification from Iraq. This prestigious certification stands as proof of our resolute commitment to ensuring the highest standards of quality, safety, and
Bulletin Venus Remedies Receives Malaysian PIC/S GMP Approval for Pre-Filled Syringe Facility Venus Remedies is thrilled to announce a major achievement: our pre-filled syringe (PFS) manufacturing unit in Baddi has been awarded the prestigious PIC/S GMP certification by Malaysia’s National Pharmaceutical Regulatory Agency (NPRA). This is the first time our PFS facility has received accreditation under the Pharmaceutical Inspection Co-operation
Bulletin Breaking Barriers with Epigenetics in the Fight Against AMR We are delighted to share that Mr. Saransh Chaudhary, President of Global Critical Care at Venus Remedies Ltd and CEO of Venus Medicine Research Centre, has authored a compelling article published in Hindustan Times E-Paper. This insightful piece, titled "Opening Frontiers with Epigenetics in Battle Against AMR," sheds light on
Bulletin Venus Remedies Leads Conversations on Breakthrough Diagnostic Technologies In alignment with Venus Remedies’ commitment to driving innovation in healthcare, our President of Global Critical Care, Mr. Saransh Chaudhary, recently shared valuable insights with India Pharma Outlook. In this engaging interview, Mr. Chaudhary discussed the critical areas of sepsis and antimicrobial resistance (AMR), illuminating how innovations in diagnostics and
Events Venus Remedies Shaping Healthcare at CPhI Milan 2024 Milan, Italy – 8-10 October 2024 Venus Remedies was once again thrilled to be a part of CPhI this year, a significant global event for the pharmaceutical industry held in the stunning city of Milan. This event brought together key industry leaders from across the globe, highlighting the importance of innovation,
Accreditations & Approvals Venus Remedies Secures Key Approvals in Multiple Markets Pharma major Venus Remedies Limited has recently made significant progress in its global expansion by obtaining marketing approvals (MAs) for a wide range of drugs in different countries. We’re excited to share that Carboplatin and Carbol have been approved in Morocco, along with Bortezomib, Gemcitabine, Cefepime, and Oxaliplatin in
Bulletin Venus Showcases Key Brands at ROSA CON 2024 Venus recently participated in the prestigious ROSA CON 2024, a zonal conference focusing on orthopedic specialties held in Bikaner. This event gathered leading orthopedic professionals and industry experts, providing a vital platform for sharing knowledge and advancing practices in the field. During the conference, Venus proudly showcased its prominent brands:
Bulletin Venus Remedies Joins AMR Vivli to Combat Antimicrobial Resistance Venus Remedies is proud to announce its official membership in AMR Vivli, a global platform dedicated to sharing critical data on antimicrobial resistance (AMR). Supported by the Wellcome Trust, AMR Vivli provides a crucial platform for researchers, healthcare organizations, and industry leaders to collaborate in combating AMR, which has become
Publications R3SET's Innovative Wellness Products Spotlighted in Harper's Bazaar R3SET, our brand dedicated to enhancing daily wellness rituals through innovative and sustainable solutions, has been featured in the prestigious Harper's Bazaar magazine. The two-page article in the July 2024 edition, found on pages 78 and 79, highlights our unique approach and extensive product range that cater to a variety
Awards Venus Remedies Honored with Excellence in Governance & Statutory Compliance Award Venus Remedies Limited has been honored with the prestigious Excellence in Governance & Statutory Compliance Award by the PHD Chamber of Commerce, Chandigarh, at the HR Conclave 2024. This esteemed recognition underscores our unwavering commitment to achieving the highest standards in governance and statutory compliance. A Testament to Our Commitment Out
Events Venus Remedies Hosts Comprehensive CMEs Across Multiple Locations In a concerted effort to enhance medical education and address critical healthcare challenges, Venus Remedies organized a series of Continuing Medical Education (CME) sessions throughout June 2024. These CMEs, held across various locations, focused on the pressing issue of antimicrobial resistance (AMR) and other critical medical topics. The sessions were
Accreditations & Approvals Venus Remedies Secures Major Tenders from UNICEF and PAHO to Enhance Global Healthcare Venus Remedies Limited, a global leader in the pharmaceutical industry, has achieved significant milestones by securing two prestigious tenders from globally renowned organizations—UNICEF and the Pan American Health Organization (PAHO). These wins mark a pivotal moment in the company's journey towards enhancing healthcare access and outcomes worldwide. UNICEF Tender
Accreditations & Approvals Venus Remedies Secures Registrations for its Unit-2 in Baddi and Venus Pharma GmbH from Kuwait Venus Remedies Limited is delighted to announce the successful registration of our Unit-2 in Baddi and Venus Pharma GmbH from Kuwait, alongside obtaining Marketing Authorizations (MAs) for Carboplatin 450 MG/45 ML. These achievements mark significant milestones in our ongoing commitment to expanding our global footprint and enhancing our pharmaceutical
Publications There’s a Pressing Need to Implement Antibiotic Protocol in All Hospitals We are pleased to share that an insightful article authored by Mr. Saransh Chaudhary, President of GCC and CEO of Venus Medicine Research Centre (VMRC), has been featured in the renowned publication Down To Earth. The article, titled "There’s a Pressing Need to Implement Antibiotic Protocol in All Hospitals,
Publications Pharma Firms Must Come Together, Ensure Access to Antibiotics in Poor Countries to Take on Superbugs We are thrilled to announce that an article authored by Mr. Saransh Chaudhary, President of GCC and CEO of Venus Medicine Research Centre (VMRC), has been prominently featured in Pharma Focus Asia. The article, titled "Pharma Firms Must Come Together, Ensure Access to Antibiotics in Poor Countries to Take on
Publications Featured Article on IP Laws and Generic Manufacturing Featured in ET Healthworld We are delighted to announce that an article authored by Mr. Saransh Chaudhary, President of GCC and CEO of Venus Medicine Research Centre (VMRC), has been prominently featured in ET Healthworld on the occasion of World Intellectual Property Day. The article, titled "Balancing IP Laws and Generic Manufacturing to Propel,
Accreditations & Approvals Featured Venus Remedies Secures Coveted UNICEF Approval for Global Impact Venus Remedies Limited, a leading pharmaceutical company with a global footprint, is proud to announce its recent attainment of Good Manufacturing Practices (GMP) approval from the United Nations Children's Fund (UNICEF). This approval signifies a significant milestone for the company, highlighting its unwavering commitment to delivering top-tier pharmaceutical solutions worldwide.
Accreditations & Approvals Featured Empowering Innovation: Venus Remedies Receives Incentive under Government's PLI Scheme In a testament to its commitment to innovation and growth, Venus Remedies Limited proudly announces its successful acquisition of an incentive under the Government of India's Production Linked Incentive (PLI) scheme. The company has secured a substantial incentive amounting to ₹7.5 crore, representing 75% of the total incentive for
